{
    "SPADE_N_13981": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13981",
            "Peptide Name": "TPk  (synthetic AMPs, cell-penetrating; XXA, UCLL1c)",
            "Source": "Neutrophil granules",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "VRRFKWWWKFLRR",
            "Sequence Length": 13,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 1964.37,
            "PI": 12.0,
            "Hydrophobicity": -1.15,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Bahnsen JS, Franzyk H, Sayers EJ, Jones AT, Nielsen HM.2015",
                    "Reference": "Pharm Res. 2015 May;32(5):1546-56. doi: 10.1007/s11095-014-1550-9.PubMed",
                    "Title": "Cell-penetrating antimicrobial peptides - prospectives for targeting intracellular infections"
                }
            ],
            "Frequent Amino Acids": "RWF",
            "Absent Amino Acids": "ACDEGHIMNOPQSTUY",
            "Basic Residues": 6,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 7,
            "Polar Residues": 7,
            "Positive Residues": 6,
            "Negative Residues": 0,
            "Net Charge": 6,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is most similar (84.62%) toTritrpticin.  R: 23%.Activity: active against S. aureus demonstrated in vitro.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_09256",
                    "Similarity": 1.0,
                    "Sequence": "GVRCVRRGVRCVRR"
                },
                {
                    "SPADE_ID": "SPADE_N_09258",
                    "Similarity": 1.0,
                    "Sequence": "GVRVRRGVRVRR"
                },
                {
                    "SPADE_ID": "SPADE_UN_00885",
                    "Similarity": 1.0,
                    "Sequence": "RVVRVVRRVVRR"
                }
            ]
        }
    }
}